$39.07
0.140.36%
At Close: -
$39.00
-0.07-0.18%
After Hours: Sep 20, 4:53 PM EDT
15 minutes delayed
Collegium Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Collegium Pharmaceutical using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $1.62 | $1.51 | 7.28 % |
Mar 2024 | 2024-05-09 | $1.45 | $0.75 | 93.3 % |
Dec 2023 | 2024-02-22 | $1.58 | $0.66 | 139.4 % |
Sep 2023 | 2023-11-07 | $1.34 | $0.52 | 157.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $145.28M | $143.94M | 0.93 % |
Mar 2024 | 2024-05-09 | $144.92M | $147.49M | -1.74 % |
Dec 2023 | 2024-02-22 | $149.75M | $147.82M | 1.30 % |
Sep 2023 | 2023-11-07 | $136.71M | $138.53M | -1.31 % |
Collegium Pharmaceutical (COLL) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $1.62, which beat the estimate of $1.51.
The Actual Revenue was $145.3M, which beat the estimate of $143.9M.
Browse earnings estimates, EPS, and revenue on all stocks.